DK0452850T3 - 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents
4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidlerInfo
- Publication number
- DK0452850T3 DK0452850T3 DK91105972T DK91105972T DK0452850T3 DK 0452850 T3 DK0452850 T3 DK 0452850T3 DK 91105972 T DK91105972 T DK 91105972T DK 91105972 T DK91105972 T DK 91105972T DK 0452850 T3 DK0452850 T3 DK 0452850T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxothiazoldinyl
- butynylamines
- pharmaceuticals
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/509,280 US5034392A (en) | 1990-04-16 | 1990-04-16 | 4-(3-(4-oxothiazolidinyl)butynylamines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0452850T3 true DK0452850T3 (da) | 1998-09-23 |
Family
ID=24025983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91105972T DK0452850T3 (da) | 1990-04-16 | 1991-04-15 | 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |
Country Status (26)
Country | Link |
---|---|
US (1) | US5034392A (ko) |
EP (1) | EP0452850B1 (ko) |
JP (1) | JPH07119223B2 (ko) |
KR (1) | KR0163598B1 (ko) |
AR (1) | AR248402A1 (ko) |
AT (1) | ATE163010T1 (ko) |
AU (1) | AU636972B2 (ko) |
BG (1) | BG60066B2 (ko) |
CA (1) | CA2040489C (ko) |
CZ (1) | CZ284447B6 (ko) |
DE (1) | DE69128845T2 (ko) |
DK (1) | DK0452850T3 (ko) |
ES (1) | ES2112844T3 (ko) |
FI (1) | FI94755C (ko) |
GR (1) | GR3026319T3 (ko) |
HU (1) | HUT61017A (ko) |
IE (1) | IE911257A1 (ko) |
IL (1) | IL97852A (ko) |
MX (1) | MX25359A (ko) |
NO (1) | NO300134B1 (ko) |
NZ (1) | NZ237811A (ko) |
PL (1) | PL165488B1 (ko) |
PT (1) | PT97371B (ko) |
RO (1) | RO108683B1 (ko) |
RU (1) | RU2001914C1 (ko) |
ZA (1) | ZA912783B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
US5194436A (en) * | 1991-01-10 | 1993-03-16 | Hoechst-Roussel Pharmaceuticals Inc. | 1-piperazinyl-2-butenes and -2-butynes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
EP0316723B1 (en) * | 1987-11-20 | 1992-09-30 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments |
-
1990
- 1990-04-16 US US07/509,280 patent/US5034392A/en not_active Expired - Lifetime
-
1991
- 1991-04-09 BG BG094208A patent/BG60066B2/bg unknown
- 1991-04-12 NZ NZ237811A patent/NZ237811A/en unknown
- 1991-04-12 FI FI911783A patent/FI94755C/fi not_active IP Right Cessation
- 1991-04-12 RO RO147316A patent/RO108683B1/ro unknown
- 1991-04-12 AR AR91319454A patent/AR248402A1/es active
- 1991-04-15 JP JP3109867A patent/JPH07119223B2/ja not_active Expired - Fee Related
- 1991-04-15 ES ES91105972T patent/ES2112844T3/es not_active Expired - Lifetime
- 1991-04-15 DE DE69128845T patent/DE69128845T2/de not_active Expired - Fee Related
- 1991-04-15 CZ CS911065A patent/CZ284447B6/cs not_active IP Right Cessation
- 1991-04-15 KR KR1019910005987A patent/KR0163598B1/ko not_active IP Right Cessation
- 1991-04-15 MX MX25359A patent/MX25359A/es unknown
- 1991-04-15 AT AT91105972T patent/ATE163010T1/de not_active IP Right Cessation
- 1991-04-15 ZA ZA912783A patent/ZA912783B/xx unknown
- 1991-04-15 HU HU911239A patent/HUT61017A/hu unknown
- 1991-04-15 RU SU914895050A patent/RU2001914C1/ru active
- 1991-04-15 IE IE125791A patent/IE911257A1/en not_active IP Right Cessation
- 1991-04-15 PT PT97371A patent/PT97371B/pt not_active IP Right Cessation
- 1991-04-15 AU AU75028/91A patent/AU636972B2/en not_active Ceased
- 1991-04-15 CA CA002040489A patent/CA2040489C/en not_active Expired - Fee Related
- 1991-04-15 PL PL91289892A patent/PL165488B1/pl unknown
- 1991-04-15 EP EP91105972A patent/EP0452850B1/en not_active Expired - Lifetime
- 1991-04-15 NO NO911465A patent/NO300134B1/no unknown
- 1991-04-15 IL IL9785291A patent/IL97852A/en not_active IP Right Cessation
- 1991-04-15 DK DK91105972T patent/DK0452850T3/da active
-
1998
- 1998-03-11 GR GR980400510T patent/GR3026319T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964654D0 (no) | Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
DK368480A (da) | Optisk aktive 1,4-dihydropyridiner fremgangsmaader til deres fremstilling og deres anvendelse som laegemidler | |
NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
DK641589A (da) | N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer | |
NO881164L (no) | Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter. | |
NO994671D0 (no) | Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika | |
DK0885234T3 (da) | Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
NO952677D0 (no) | Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater | |
NO932120D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
NO943794L (no) | 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling | |
DK0903339T3 (da) | Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament | |
DK660788D0 (da) | 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel | |
NO982708D0 (no) | Nye fenylamidinderivater, fremgangsmÕte for fremstilling derav og deres anvendelse som legemidler | |
DK219685A (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler | |
DK0727416T3 (da) | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som | |
NO890187D0 (no) | 2-(3,4-dihydroksyfenyl)etylaminer, deres fremstilling og anvendelse som farmasoeytika. | |
NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
NO904576L (no) | Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter. | |
NO953321D0 (no) | 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler | |
DK131387A (da) | 1,1-disubstituerede cyclopropanderivater, deres fremstilling og anvendelse som antimykotika | |
DK0452850T3 (da) | 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
NO921908D0 (no) | Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter | |
DK619989A (da) | Dipeptidderivater, deres fremstilling og anvendelse som laegemidler | |
NO955242D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse | |
NO871744D0 (no) | Nye benzotiazinonderivater, fremgangsmaate til deres fremstilling, legemidler som inneholder disse og deres anvendelse. |